Literature DB >> 5893609

Amnesic properties of scopolamine and brain acetylcholine in the rat.

A Pazzagli, G Pepeu.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1965        PMID: 5893609     DOI: 10.1016/0028-3908(65)90025-0

Source DB:  PubMed          Journal:  Int J Neuropharmacol        ISSN: 0375-9458


× No keyword cloud information.
  8 in total

Review 1.  Muscarinic and nicotinic acetylcholine receptor agonists and allosteric modulators for the treatment of schizophrenia.

Authors:  Carrie K Jones; Nellie Byun; Michael Bubser
Journal:  Neuropsychopharmacology       Date:  2011-09-28       Impact factor: 7.853

2.  Contrasting effects of scopolamine on mice trained simultaneously with two different schedules of avoidance conditioning.

Authors:  A Oliverio
Journal:  Psychopharmacologia       Date:  1967

3.  Effects of physostigmine, scopolamine, and mecamylamine on the sleeping time induced by ketamine in the rat.

Authors:  E M Figallo; L B Wingard
Journal:  Psychopharmacology (Berl)       Date:  1979-03-14       Impact factor: 4.530

Review 4.  Modes and models of forebrain cholinergic neuromodulation of cognition.

Authors:  Michael E Hasselmo; Martin Sarter
Journal:  Neuropsychopharmacology       Date:  2010-07-28       Impact factor: 7.853

5.  Nicotine-produced relearning deficit in C57BL/6J and DBA/2J mice.

Authors:  D M Gilliam; K Schlesinger
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

6.  Effects of scopolamine, pilocarpine, and oxotremorine on the exploratory behavior of two psychogenetically selected lines of rats in a complex maze.

Authors:  J R Martin; D H Overstreet; P Driscoll; K Bättig
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

Review 7.  Activation of M1 and M4 muscarinic receptors as potential treatments for Alzheimer's disease and schizophrenia.

Authors:  Daniel J Foster; Derrick L Choi; P Jeffrey Conn; Jerri M Rook
Journal:  Neuropsychiatr Dis Treat       Date:  2014-01-28       Impact factor: 2.570

Review 8.  Modeling Alzheimer's disease in transgenic rats.

Authors:  Sonia Do Carmo; A Claudio Cuello
Journal:  Mol Neurodegener       Date:  2013-10-25       Impact factor: 14.195

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.